<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SCU-China_practice_hp skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SCU-China/practice/hp</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Team:SCU-China - 2018</TITLE></P><DIV style="width:100%"><DIV><UL class="navbar" id="navbar"><LI><A href="https://2018.igem.org/Team:SCU-China">Home</A></LI><LI><A>Project</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/project/overview">Overview</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/project/interlab">Interlab</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/project/regulation">Precise Regulation</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/project/circuits">Logic Circuits</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/project/indigo">CRISProgrammer of Indigo</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/project/parts">Parts</A></LI></UL><LI><A>Modeling</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/modeling/prediction">Off Target Prediction</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/modeling/algorithm">Orthogonal promoter construction Algorithm</A></LI><LI><A>Human practice</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/practice/hp">Integrated Human Practice</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/practice/collaboration">Collaboration</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/practice/meet">Meet Up</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/practice/education">Education &amp; Public</A></LI><LI><A>Judging</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/judging/human">Integrated Human Practice</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/judging/improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/judging/model">Model</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/judging/demonstrate">Demonstrate</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/attribution">Attribution</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/safety">Safety</A></LI><LI><A href="https://2018.igem.org/Team:SCU-China/notebook">Notebook</A></LI></DIV><DIV class="head"><DIV class="headline sides"><DIV>Integrated Human Practice</DIV></DIV></DIV><DIV class="content"><DIV class="main"><DIV class="maincontent"><DIV class="subtitle">01.	Interview with Dr. Luo.</DIV><P>In order to better solve the problems that other teams had raised in CCiC, the difficulties we encountered
                    in the process of experiments, and the significance and prospects of the project, we decided to interview
                    Professor Yunzi Luo, a researcher at the State Key Laboratory of Biotherapy of Sichuan University.
                    Dr. Luo is mainly engaged in the research of synthetic biology, molecular biology and biochemistry,
                    and carries out research on the bioactive molecules excavation, biosynthesis mechanism and efficient production.
                    As she was the instructor of previous iGEM team, we hoped to get practical advice and solutions to the problem from her.
                </P><DIV class="subtitle">02. Interview with Dr. Huang</DIV><P>Dr. Fei Huang is the chairman of a biology company who is in a long-term cooperation with SCU_iGEM as
                    a consultant. When we were previewing and having defense for our projects, Dr. Huang expressed his
                    interest in the project about using CRISPR system to adjust and control the process of indigo production
                    and dying. After the defense, we acquired that Dr. Huang also had a project related to indigo, so we
                    consulted him about the potential problems our system might have. And since he is familiar with the
                    industrial application of biotechnology and the production process of biological products, we also
                    asked him about the possibility of using our CRISPR system in the industrial production of indigo.
                </P></DIV></DIV></DIV><DIV class="footer">SCU_China 2018 iGEM Team</DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>